# Safety And Pharmacokinetics Study Of PF-04287881 In Healthy Adults

> **NCT00793000** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 80 (actual)

## Conditions studied

- Respiratory Tract Infections

## Interventions

- **DRUG:** PF-04287881
- **DRUG:** Placebo
- **DRUG:** PF-04287881
- **DRUG:** Placebo
- **DRUG:** PF-04287881
- **DRUG:** Placebo
- **DRUG:** PF-04287881
- **DRUG:** Placebo
- **DRUG:** PF-04287881
- **DRUG:** Placebo
- **DRUG:** PF-04287881
- **DRUG:** Placebo
- **DRUG:** PF-04287881
- **DRUG:** Placebo
- **DRUG:** PF-04287881
- **DRUG:** Placebo
- **DRUG:** PF-04287881
- **DRUG:** Placebo
- **DRUG:** PF-04287881
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00793000
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2011-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00793000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00793000, "Safety And Pharmacokinetics Study Of PF-04287881 In Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00793000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
